![](/img/cover-not-exists.png)
P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature may Identify Non-Responders to Anti PD-1 Treatment in NSCLC
Amann, A., Gamerith, G., Bader, A., Hahn, W., Tschida, C., Cope, T., Audetat, A., Mellert, H., Pestano, G., Zwierzina, H.Volume:
13
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.1708
Date:
October, 2018
File:
PDF, 136 KB
2018